Previous studies have suggested the contribution of polymorphisms in EPCAM gene to the increased risk of breast cancer and cervical cancer[15], [16], and our recent study also showed that non-synonymous SNP rs1126497 in EPCAM gene may be a potential prognostic marker for NSCLC patients[17]. Here, EPCAM is linked to breast cancer.